Skip Navigation LinksDrugSafetyProgram

Food and Drug Branch (FDB)

 FDB Home Page

 Contact

Main Telephone:

(800) 495-3232

 

Email:

FDBinfo@cdph.ca.gov

 

Address (Courier Delivery):

California Department of Public Health - Food and Drug Branch

1500 Capitol Ave, MS 7602

Sacramento, CA 95814

 

Address (Non-Courier Delivery):

California Department of Public Health - Food and Drug Branch

P.O. Box 997435, MS 7602

Sacramento, CA 95899

Drug Safety Program

The Drug Safety Program's mission is to promote and improve the health and well-being of all California residents and to facilitate the growth and vitality of California drug, cosmetic, and other consumer product industries.  This mission is accomplished by an integrated regulatory and science based program that utilizes education, investigation, and enforcement to assure that products are not adulterated, misbranded or falsely advertised.

The vision is to be recognized worldwide as a dynamic, scientifically based, accountable organization in partnership with all who seek the betterment of public health, by promoting the highest standards of safety, quality and technology for drugs, cosmetics, and related products.

 News and Updates

 

Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic

FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review

Janssen COVID-19 Vaccine Fact Sheet for Healthcare Providers Administering Vaccine

Janssen COVID-19 Vaccine Emergency Use Authorization (EUA) of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019 (COVID-19) in Individuals 18 Years of Age and Older

Bryant Ranch Prepack Issues Voluntary Nationwide Recall of Spironolactone 25 mg and 50 mg Tablets Due to Mislabeling with the Incorrect Strength (Revision to Press Release with Same Title Dated 3/9/2021. Revision Includes Number of Bottles Impacted by Recall)

FDA Takes Action to Place All Alcohol-Based Hand Sanitizers from Mexico on Import Alert to Help Prevent Entry of Violative and Potentially Dangerous Products into U.S., Protect U.S. Consumers

FDA Provides Policyfor Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol, IncludingDuring COVID-19 Public Health Emergency - Drug Information Update

FDA Moderna COVID-19 Vaccine Fact Sheet for Recipients, Caregivers, and Healthcare Providers Administering Vaccine in Various Langauges

FDA Pfizer-BioNTech COVID-19 Vaccine Fact Sheet for Recipients and Caregivers in Various Languages

FDA: Protect Your Family From Fraudulent Flu Products

Hand Sanitizer Advisory (PDF)

Benadryl (diphenhydramine): Drug Safety Communication - Serious Problems with High Doses of the Allergy Medicine

CDC Health Advisory on Serious Adverse Health Events Associated with Methanol-based Hand Sanitizers (PDF)

FDA Warns Consumers of Risk of Methanol Contamination in Certain Hand Sanitizers

Coronavirus (COVID-19) Update: FDA Takes Action to Warn, Protect Consumers from Dangerous Alcohol-Based Hand Sanitizers Containing Methanol

FDA advises consumers not to use hand sanitizer products manufactured by Eskbiochem

Temporary Alcohol-Based Hand Sanitizer Manufacturer Registration Process (PDF)

Governor Newsom Signs Executive Order on Actions in Response to COVID-19 6.5.20

Executive Order N-68-20 (PDF)

Drug License Fees (Effective September 1, 2020) (PDF)

Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds

Drug Safety Program FAQs (PDF)

Drug Safety Program Licensing Requirements (PDF)

Page Last Updated :